Treatments for Conditions of the Eye
More than 2 million Americans are believed to have some type of glaucoma – and half of them do not know it. People in the early stages of the disease rarely notice any symptoms, so it’s vitally important to be tested for glaucoma regularly, beginning at about age 35. Ninety percent of glaucoma patients have open-angle glaucoma. Although this condition cannot be cured, it can usually be controlled. Early treatment may also minimize vision loss. To control glaucoma, our doctors may prescribe one of a few different treatments such as medicine or surgery. These options include glaucoma drops, laser surgery known as Selective Laser Trabeculoplasty (SLT) to lower the pressure in the eye, an iStent in conjunction with cataract surgery (for more information see our partner glaukos.com.) or an Omni procedure independent of cataract surgery (for more information see our partner omnisurgical.com.)
Diabetes (Diabetic Retinopathy)
Diabetes is a disease that affects blood vessels throughout the body, particularly vessels in the kidneys and eyes. Diabetic retinopathy results when the blood vessels in the eyes grow scar tissue and leak fluid or blood, impairing the retina’s ability to detect and transmit images. During the early stages of diabetic retinopathy, vision is typically not affected. However, when retinopathy becomes advanced, vision tends to become hazy and occasionally results in a complete loss of vision. Diabetes can also lead to glaucoma and cataracts. In addition, diabetes can trigger retinal detachment, which can result in blindness if left untreated. Regular eye exams are crucial in preventing and treating diabetic retinopathy.
Genstler Eye Center is pleased to offer our patients PROKERA®, a new treatment for chronic Dry Eye that heals the surface of your eye (cornea) and returns your eye to a normal, healthy state. PROKERA is a simple procedure and is easily inserted and removed in our office. Once removed your cornea is rejuvenated so you can see and feel better. In a recent patient survey, 93% of patients with Dry Eye said they felt better after treatment with PROKERA. PROKERA is similar to a contact lens and is made of amniotic tissue, which is known for its natural therapeutic actions and heals your eye faster with less pain, scarring, and inflammation. The amniotic tissue used in PROKERA is provided by a tissue bank regulated by the FDA and has passed numerous quality control tests making it safe and effective. Clinical studies have shown PROKERA reduces the signs and symptoms of Dry Eye, and helps soothe pain, heal the eye, and improve vision. PROKERA is the only U.S. Food and Drug Administration (FDA)-cleared therapeutic device that reduces inflammation and promotes healing. For more information visit www.prokerainfo.com.
Play the video below to watch a special message from PROKERA.
Macular degeneration affects cells in the macula – the part of the retina responsible for central vision – which impairs your ability to read, drive and recognize people. Although macular degeneration leaves peripheral vision unaffected, the disease can be quite debilitating in its advanced stage. The primary cause of macular degeneration is not known. Age Related Macular Degeneration, often called AMD or ARMD, is the leading cause of vision loss and blindness among Americans who are 65 and older. There is no cure for macular degeneration yet. However, there are some treatments that delay the progression and possibly even improve vision. The doctors at Genstler Eye Center can provide testing and examinations to monitor and treat the disease.